URRENT treatments for comatose head-injured patients often include three vasoreactivity-based therapies. Mild hyperventilation is used to help control intracranial hypertension and assumes effective CO 2 reactivity. 10, 13, 49 Maintenance of an adequate CPP is advocated to optimize CBF and assumes a relative degree of preserved PA. 52 Use of metabolic suppressive therapy with high-dose pentobarbital or propofol for refractory intracranial hypertension is based on the assumption that there is a degree of retained metabolic suppression reactivity. 9, 53 These components of vasoreactivity form the foundation for current head injury treatment strategies, namely hyperventilation therapy, CPP therapy, and pharmacological metabolic suppressive therapy. Despite widespread use of these therapies, it is generally acknowledged that vasoreactivity is often seriously impaired after injury. Vascular dysfunction has been implicated in the development of posttraumatic cerebral ischemia, 7, 8, 37 cerebral hyperemia, 25, 30, 32, 46 Object. Contemporary management of head-injured patients is based on assumptions about CO 2 reactivity, pressure autoregulation (PA), and vascular reactivity to pharmacological metabolic suppression. In this study, serial assessments of vasoreactivity of the middle cerebral artery (MCA) were performed using bilateral transcranial Doppler (TCD) ultrasonography.
CPP, 51, 52 and in whom and when to implement metabolic suppressive therapy. 17, 62 Although there have been numerous studies of posttraumatic vasoreactivity, in none have CO 2 reactivity, PA, and metabolic suppression reactivity been assessed in a combined and serial manner. In the present study we investigated these components of vasoreactivity by using TCD ultrasonography because it is a noninvasive method that allows simultaneous assessment of both cerebral hemispheres. Also, TCD has been shown to provide precise and reproducible assessments of CO 2 reactivity, PA, and metabolic suppression reactivity in healthy individuals and in patients with a variety of cerebral disorders. 1, 2, 21, 27, 58, 59 Specific objectives of this study included the following: 1) defining relative differences in the temporal pattern and degree of impairment for CO 2 reactivity, PA, and metabolic suppression reactivity; 2) determining whether known predictors of outcome after head injury are important determinants of impaired vasoreactivity; and 3) determining the impact of vasoreactive impairment on neurological outcome.
Clinical Material and Methods

Patient Population
This study included 28 patients receiving mechanical ventilation for moderate or severe head injury, who were admitted within 24 hours of injury to the UCLA Medical Center (26 patients) or Harbor-UCLA Medical Center (two patients) between August 1996 and March 2000. Patients were eligible if they were age 16 years or older; had sustained a closed or penetrating brain injury with abnormal findings on CT scans; had a postresuscitation GCS score 57 of 3 to 12 (or deterioration to a GCS score Յ 12), and required ICP monitoring.
General Management Protocol
Patients were admitted to the ICU after initial stabilization or surgical evacuation of an intracranial hematoma and were treated in accordance with a Level I Trauma Center protocol. Management goals included maintenance of ICP at less than 20 mm Hg and CPP greater than 70 mm Hg. In most patients a jugular bulb catheter was placed to monitor SjvO 2 .
Vasoreactivity Test Battery
Testing consisted of an assessment of right and left hemisphere CO 2 reactivity, PA, and metabolic suppression reactivity performed over a 2-to 3-hour period in the ICU. The first 10 patients studied underwent one or two clinical testing sessions, which consisted of a hyperventilation trial for CO 2 reactivity, followed by a transient phenylephrine-induced blood pressure elevation to assess PA. As described later, five of these initial patients also underwent a trial of metabolic suppression with propofol. The 18 subsequent patients were prospectively enrolled in the study, in which the goal was to perform a complete battery of vasoreactivity tests on postinjury Days 0, 1, 2, 4, 6, and 8. This protocol was approved by the institutional review boards of both the UCLA and Harbor-UCLA Medical Centers.
Testing was performed only in patients who had undergone intubation and were hemodynamically stable. Testing sessions were postponed in patients with severe cerebral vasospasm (MCA velocity Ͼ 180 cm/second) or low CBF (Ͻ 25 ml/100 g/min) identified using the intravenous 133 Xe clearance technique (Cerebrograph Cortexplorer 10; Ceretronix, Randers, Denmark). 45, 46 Efforts were made to avoid changes in ventilator settings or vasopressor or sedative doses immediately before testing. Mannitol use was also avoided during this time.
Physiological Parameters and TCD Ultrasonography
Recordings were made of the mean blood flow velocity of the right and left MCA and extracranial ICA by using a 2-MHz probe. These vessels were insonated through the temporal (MCA) and submandibular (extracranial ICA) windows according to the principles described by Aaslid, et al. 3 Continuous monitoring of bilateral MCA flow velocities for vasoreactivity testing was performed with a TCD unit similar to that used for conventional TCD studies (Neuroguard Cerebrovascular Diagnostic System; Nicolet Biomedical, Inc., Madison, WI) but equipped with an analog output device. Bilateral 2-MHz ultrasound transducers were fixed to an adjustable headband to prevent motion. The transducers were connected to a dedicated spectral analyzer that continuously calculated the mean V MCA . The V MCA represents the flow velocity of the MCA averaged over four cardiac cycles. The mean right and left V MCA , MAP, ICP, and ETCO 2 were continuously recorded. Data were sampled at a rate of 10 Hz but were averaged every 6 seconds to ensure independence of data points (that is, to account for the averaging of V MCA over four cardiac cycles and the calculation of ETCO 2 with each inspiratory breath).
Carbon Dioxide Reactivity
The mean V MCA was recorded during a 10-minute baseline monitoring period, followed by a 10-minute hyperventilation trial to lower ETCO 2 by 6 to 8 mm Hg. The change in arterial CO 2 was confirmed by arterial blood gas analysis. Studies were excluded from analysis if the ETCO 2 changed less than 3 mm Hg. In one case in which the patient's baseline CBF was less than 30 ml/100 g/min, ETCO 2 was increased with hypoventilation to avoid inducing cerebral ischemia. Relative CO 2 reactivity was defined as the %∆ in mean V MCA per millimeter of mercury change in ETCO 2 (%∆V MCA /mm Hg) as adapted from Klingelhöfer and Sander. 27 Based on their report, the normal range for CO 2 reactivity was defined as 3.7 Ϯ 1 %∆V MCA /mm Hg.
Pressure Autoregulation
After completion of CO 2 reactivity testing and a 10-minute baseline monitoring period, PA was assessed by monitoring the response of V MCA to a phenylephrine-induced elevation in MAP of 10 to 15 mm Hg. Results were excluded from analysis if MAP changed less than 8 mm Hg. Because of the occasional drift in ETCO 2 that occurred during PA testing, all flow velocities were corrected to an ETCO 2 of 34 mm Hg by using the patient's own hemispheric CO 2 reactivity values obtained during the same study session. A PA index was calculated as defined by Tiecks, et al. 59 The average MAP and V MCA before and after the MAP change were used to calculate an eCVR1 and eCVR2 as follows: eCVR = MAP/V MCA . Autoregulatory capacity was defined as %∆eCVR/%∆MAP from MAP1 to MAP2, where %∆eCVR = (eCVR2 Ϫ eCVR1)/ eCVR1 and %∆MAP = (MAP2 Ϫ MAP1)/MAP1. 59 The PA index was then calculated as the %∆eCVR/%∆MAP in response to phenylephrine. A PA index of 100% indicates a complete compensatory change in eCVR, whereas a PA index of 0% indicates a completely pressure-passive cerebrovasculature. A negative PA index indicates a paradoxical decrease in eCVR to blood pressure elevation (normal PA index was defined as Ն 70%). 59 During four study sessions for two patients, MAP was decreased rather than increased. These two patients had high baseline ICPs (mean 33 Ϯ 8 mm Hg) during these study sessions and their ICPs had been noted to increase with elevated MAP.
Metabolic Suppression Reactivity
After CO 2 reactivity and PA testing were completed, response to metabolic suppression was evaluated by monitoring the change in V MCA to propofol-induced electroencephalographically defined burst suppression. Propofol (Diprivan, Astra Zeneca, Wilmington, DE) was chosen rather than pentobarbital because the former has an ultrashort plasma halflife, it does not alter CO 2 reactivity or PA, 4, 40, 55, 59 and it is being increasingly used for sedation and ICP control in head-injured patients. 24, 39 Propofol was started with a loading dose (1 mg/kg intravenously over 10 minutes) and then titrated to achieve 6 to 10-second burst suppression periods on electroencephalography, with a maximum infusion rate of 200 g/kg/min. During four study sessions in two patients, electroencephalography was unavailable and propofol was increased to 160 to 200 g/kg/min, which produces burst suppression in the majority of individuals. Because infusions of metabolic suppressive agents such as propofol and pentobarbital often cause transient hypotension, 14 a constant MAP was maintained with phenylephrine delivered as needed during propofol administration. Studies were excluded from analysis if the MAP changed more than 10 mm Hg from the baseline during induction of burst suppression. As with PA testing, to account for changes in ETCO 2 over the course of propofol administration, all flow velocities were corrected to an ETCO 2 value of 34 mm Hg based on the patient's own hemispheric CO 2 reactivity values from the same study session. Metabolic suppression reactivity was defined as the percentage change in the CO 2 -corrected V MCA from baseline to electroencephalographically confirmed burst suppression. Previous studies in animals and healthy humans have shown a CBF decrease ranging from 38 to 58% following propofol-induced burst suppression. 20, 22, 60 For our study, a normal metabolic suppression reactivity was defined as a decrease in CO 2 -corrected V MCA of 30% or more.
Hemispheric Asymmetry: Better Compared With Worse Hemispheres
To assess the degree of interhemispheric differences for CO 2 reactivity, PA, and metabolic suppression reactivity in each individual, the hemisphere with the "better" and that with the "worse" value was identified for each study. All † For CO 2 reactivity, the mean MAP1 was 104 Ϯ 14 and the MAP2 was 104 Ϯ 13 (p = 0.76). In one CO 2 reactivity study, in which the patient received hypoventilation (ETCO 2 increased) because of low CBF, the initial and final ETCO 2 values were switched for calculating the baseline and final ETCO 2 values. The mean baseline and final ICP and SjvO 2 values were based only on studies in which hyperventilation was used.
‡ In four PA studies in two patients, the MAP was lowered because of high ICP. In these four studies, the final and baseline values were switched for calculating the MAP1 and MAP2 values. The mean baseline and final CPP and ICP values were based solely on 47 studies in which MAP was elevated. better and worse values were then normalized by dividing them by the lower limit of normal (2.7 for CO 2 reactivity, 70 for PA, and 30 for metabolic suppression) and multiplying by 100. These better and worse values were then compared. To assess interhemispheric differences in vasoreactivity studies further, interhemispheric (right compared with left) correlation analyses were performed for each type of vasoreactivity.
Predictors of Impaired Vasoreactivity: Global Factors
To determine the effects of patient age, GCS score, and hypotensive or hypoxic insults, the patients' vasoreactivity scores for CO 2 reactivity, PA, and metabolic suppression reactivity were described in terms of global average (mean of right and left) of all studies performed, and worst global vasoreactivity score. For age, patients were categorized as being older or younger than 35 years of age, 61 and for GCS score, patients were categorized as having an initial score of 3 to 5 compared with 6 or higher. Early hypotension or hypoxia was defined as a systolic blood pressure of less than 90 mm Hg, or a PaO 2 less than 60 mm Hg (or apnea), respectively, documented in the prehospital setting or within 24 hours of hospitalization.
Hemispheric Factors: CT Findings and Vasospasm
For CT findings, each patient's first two CT scans, all obtained within 8 hours of admission, were assessed for ICH overlying or within the MCA vascular territory, including epidural and subdural hemorrhage and SAH, as well as intracerebral hematomas and contusions. The MCA territory was defined by conventional criteria as described by Osborn. 47 Each hemisphere was categorized as with or without hemorrhagic lesions affecting the MCA territory. The mean hemispheric vasoreactivity scores over the postinjury period were then compared in affected and unaffected hemispheres.
The effect of MCA vasospasm was assessed by comparing hemispheres with and without vasospasm in terms of same-day ipsilateral CO 2 reactivity, PA, and metabolic suppression reactivity scores. Vasospasm in the MCA territory was defined by a mean V MCA of 120 cm/second or more, with a Lindgaard ratio 34 (V MCA /V ecICA ) of 3 or higher, where V ecICA means flow velocity in the extracranial ICA.
Use of ICP and CPP as Predictors
Correlation analyses were performed comparing the global (mean of the right and left hemisphere) vasoreactivity scores for CO 2 reactivity, PA, and metabolic reactivity to baseline ICP and CPP immediately before beginning each respective component of the test battery. To assess the effect of intracranial hypertension in more depth, studies of CO 2 reactivity, PA, and metabolic reactivity were categorized as having a baseline ICP of less than or equal to 20 mm Hg or greater than 20 mm Hg and were then compared for mean global vasoreactivity scores.
Outcome and Vasoreactivity Scores
For all patients who had completed at least one vasoreactivity test battery and in whom a 6-month GOS score was available, 23 a cumulative vasoreactivity score was derived. This score was based on whether global values for CO 2 reactivity, PA, or metabolic reactivity were in the normal range. Thus, on a given day a patient could have a cumulative vasoreactivity score of 0 (if all components were abnormal), up to a score of 3 (if all components were normal). The 6-month GOS score was then assessed as a function of this cumulative score. Both the first score (from the 1st day tested postinjury) and the average score (average of all study days) were analyzed as determinants of the GOS score.
Statistical Analysis
Most analyses involved multiple measurements over time for each individual. For these situations, continuous analyses were performed using mixed-effect linear regression models and categorical analyses were completed using mixed-effect logistic regression models. 35 For the simpler situation of one observation per subject, continuous variables were compared using a t-test for independent or dependent variables, a Pearson correlation analysis for continuous variables, and a Spearman rank-order correlation analysis for noncontinuous variables. Multiple regression analysis was used to investigate the relation of age, GCS score, and hypotension/hypoxia to the global averages and worst global scores. Significance was defined at a probability of less than 0.05, but in some instances we call attention to results that are suggestive given the small sample sizes.
Results
The 28 patients had a mean age of 33 Ϯ 13 years (range 17-63 years), a median postresuscitation GCS score of 7 (range 3-14), and 23 (82.1%) were men. Mechanisms of injury included motor vehicle accidents in 13 cases, falls in nine, gunshot wounds in two, automobiles striking pedestrians in two, a bicycle striking a pedestrian in one, and assault in one.
Number and Timing of Study Sessions
In total, 61 study sessions were performed in 28 patients. Study sessions occurred on postinjury Days 0 (eight sessions), 1 (11 sessions), 2 (13 sessions), 3 (five sessions), 4 (seven sessions), 5 (two sessions), 6 (seven sessions), 7 (one session), 8 (three sessions), 9 (three sessions), and 13 (one session). For temporal profile analysis, studies were combined within three time periods consisting of postinjury Days 0 to 1, postinjury Days 2 to 4, and postinjury Days 5 to 13, as was previously described by Martin, et al. 38 Sixteen patients underwent two to five study sessions and 12 patients were studied only once. Certain vasoreactivity studies were excluded from the final analysis for reasons outlined later. After accounting for excluded studies, a complete battery of vasoreactivity tests consisting of all three components (CO 2 reactivity, PA, and metabolic suppression testing) was performed in 32 of 61 study sessions in 14 patients.
Overall Status of Vasoreactivity
For each of the three components of the vasoreactivity battery, the baseline and final values for physiological parameters are shown in Table 1 , and the numbers of stud-ies and the numbers of patients with abnormal values are shown in Table 2 and Fig. 1 .
Carbon Dioxide Reactivity. Sixty CO 2 reactivity tests were performed in 28 patients. Two studies from one patient were excluded from analysis because ETCO 2 changed less than 3 mm Hg. Calculated from the remaining 58 studies in 28 patients, the mean CO 2 reactivity was 3.3 Ϯ 1.6 %∆V MCA /mm Hg. One or both hemispheres had below normal CO 2 reactivity in 40% of studies and the global average CO 2 reactivity was below normal in nine (32%) of 28 patients.
Pressure Autoregulation. Fifty-four PA trials were performed in 25 patients. Three studies in three patients were excluded because MAP changed less than 8 mm Hg; two patients were therefore excluded from this analysis, whereas the third, who had multiple studies, remained in the group. Calculated from the remaining 51 studies in 23 patients, the mean CO 2 -corrected PA index was 67 Ϯ 64%. One or both hemispheres had below normal PA in 69% of studies and the global average PA was below normal in 12 (52%) of 23 patients.
Metabolic Suppression Reactivity. Forty-four metabolic suppression studies were performed in 19 patients. Nine studies from six patients were excluded because the MAP changed more than 10 mm Hg from the baseline value during induction of burst suppression, leaving a total of 35 studies in 16 patients for our analysis. The mean metabolic suppression reactivity observed over all 35 studies was 14 Ϯ 13%. One or both hemispheres had below normal reactivity in 97% of studies and the global average metabolic suppression reactivity was below normal in 15 (94%) of 16 patients.
Temporal Changes in Vasoreactivity
Carbon Dioxide Reactivity. Although considerable variability was seen in hemispheric CO 2 reactivity over time, the mean values were within the normal range for each of three time periods Metabolic Suppression Reactivity. A large degree of variability was seen over time for metabolic reactivity, but unlike CO 2 reactivity and PA, there was no trend toward recovery. The mean values for hemispheric metabolic reactivity were as follows: 16 Ϯ 18% on postinjury Days 0 to 1 (26 hemispheres); 14 Ϯ 11% on postinjury Days 2 to 4 (30 hemispheres); and 9 Ϯ 10% on postinjury Days 5 to 9 (14 hemispheres) (p Ͼ 0.10 for all comparisons). The percentage of studies in which the global metabolic reactivity was normal also tended to decrease over time: 23.1% on postinjury Days 0 to 1; 6.7% on postinjury Days 2 to 4; and 0% on postinjury Days 5 to 9 (p = 0.11).
Correlation Between CO 2 Reactivity, PA, and Metabolic Reactivity
When comparing same-day and same-hemisphere vasoreactivity studies in individual patients, there was a weak correlation between CO 2 reactivity and metabolic suppression reactivity (Pearson test: r = 0.28, p = 0.02; 68 hemi- † Global average is the mean of the right and left hemispheres averaged over all study sessions for a given patient.
FIG. 1. Bar graph
showing the percentage of studies in which both, one, or neither hemisphere (white bars, light stippled bars, and dark stippled bars, respectively) had vasoreactivity scores above the lower limit of normal, defined as 2.7% or more for CO 2 reactivity, 70% or more for PA, and 30% or more for metabolic suppression reactivity. One or both hemispheres had below normal vasoreactivity scores in 40%, 69%, and 97% of study sessions (p Ͻ 0.0001) for CO 2 reactivity, PA, and metabolic suppression reactivity, respectively. spheres). The correlation was poor between PA and CO 2 reactivity (Pearson test: r = 0.013, p = 0.90; 96 hemispheres) and between PA and metabolic suppression reactivity (Pearson test: r = 0.018, p = 0.89; 66 hemispheres).
Hemispheric Asymmetry: Better Compared With Worse Hemispheres
As shown in Fig. 3 , the mean normalized scores for better compared with worse hemispheres were 133% compared with 114% for CO 2 reactivity, 120% compared with 71% for PA, and 62% compared with 31% for metabolic suppression reactivity. On average there was minimal asymmetry for CO 2 reactivity, with both hemispheres above the lower threshold of normal. For PA, the better hemisphere, on average, was normal and the worse hemisphere was impaired. For metabolic suppression reactivity, both better and worse hemispheres were severely impaired. The relative degree of asymmetry is further demonstrated by analysis of the interhemisphere correlations. These were 0.90 (SE 0.05) for CO 2 reactivity, 0.72 (SE 0.10) for PA, and 0.62 (SE 0.14) for metabolic suppression reactivity. The interhemisphere correlation for CO 2 reactivity was significantly higher than for PA and for metabolic suppression reactivity (p = 0.03).
Predictors of Impaired Vasoreactivity
Global Factors. Patient age and initial GCS score were not predictive of vasoreactive impairment. The presence of early hypotension or hypoxia was associated with a lower average global CO 2 reactivity (3 Ϯ 0.9 in 11 patients with hypotension/hypoxia compared with 3.8 Ϯ 1.5 in 17 patients without hypotension/hypoxia; p Ͻ 0.05).
Hemispheric Factors: CT Findings and Vasospasm. The presence of hemorrhagic lesions in or overlying the MCA territory was predictive of impaired ipsilateral metabolic suppression reactivity. The average hemispheric metabolic suppression reactivity was 12.5 Ϯ 8.1% for 20 injured hemispheres compared with 22.8 Ϯ 9.8% for 12 uninjured hemispheres (32 hemispheres in 16 patients, p Ͻ 0.01). Although MCA vasospasm was associated with same-day impairment of ipsilateral metabolic suppression reactivity, this difference was not statistically significant because of the small sample size. The average hemispheric metabolic suppression reactivity was 5.1 Ϯ 8.8% in seven hemispheres with same-day MCA vasospasm compared with 14.9 Ϯ 14.2% in 63 hemispheres without MCA vasospasm. See Table 3 for a summary of predictors.
Use of ICP and CPP as Predictors.
A baseline ICP of more than 20 mm Hg was used to predict globally impaired CO 2 reactivity, PA, and metabolic suppression reactivity (p Ͻ 0.05 for all comparisons; Table 4 ). As shown in Table 5 , baseline ICP also correlated negatively with
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Vasoreactivity changes after head injury 227 hemispheres (stippled bars) for CO 2 reactivity, PA, and metabolic suppression reactivity. The 100% line marks the lower limit of normal, defined as 2.7% for CO 2 reactivity, 70% for PA, and 30% for metabolic suppression reactivity. Note the relatively large differences between the better and worse hemispheres for PA and metabolic suppression reactivity compared with CO 2 reactivity. The interhemisphere correlation for CO 2 reactivity (0.90) was significantly stronger than for PA (0.72) and metabolic suppression reactivity (0.62) (p = 0.03).
CO 2 reactivity (p Ͻ 0.01), and metabolic suppression reactivity (p Ͻ 0.01), but not PA. Baseline CPP correlated strongly with CO 2 reactivity (p Ͻ 0.01) and PA index (p Ͻ 0.01) but not with metabolic suppression reactivity. Notably, abnormal PA was observed across a broad range of baseline CPP values. In 44 studies in which the baseline CPP was 70 mm Hg or more before starting a phenylephrine-induced blood pressure elevation, one or both hemispheres had impaired autoregulation in 66% of studies.
Outcome and Vasoreactivity Scores. Of the 28 patients in the overall cohort, 13 underwent a total of 28 complete vasoreactivity batteries and their 6-month GOS score was also available. The first and the average cumulative vasoreactivity scores both correlated significantly with the 6-month GOS score (Spearman correlations = 0.56 and 0.69, p Ͻ 0.05, respectively).
Illustrative Case
This 20-year-old man suffered a self-inflicted gunshot wound. His initial GCS score was 5 and a CT scan revealed a bullet track coursing through the right temporal lobe with bilateral SAH and a right temporal hematoma requiring evacuation (Fig. 4 upper left) . Vasoreactivity testing was performed on postinjury Days 0, 1, 2, and 6. As seen in Fig. 4 upper right, CO 2 reactivity was abnormal on postinjury Days 0 and 1, but normalized by postinjury Day 2. His PA and metabolic reactivity remained abnormal throughout the first 6 days (Fig. 4 lower) . For all three vasoreactivity parameters, the greatest degree of right/left asymmetry was seen on postinjury Day 0, particularly for metabolic reactivity. Although the left hemisphere demonstrated an appropriate decrease in MCA flow velocity in response to propofol-induced burst suppression, the more severely injured right hemisphere displayed a paradoxical increase in flow velocity (Fig. 5) .
Discussion
Overview of Findings
In this study of moderately and severely head injured patients, serial TCD assessments of vasoreactivity within the first 2 weeks after injury revealed significant differences in the degree of impaired CO 2 reactivity, PA, and metabolic suppression reactivity. On average, CO 2 reactivity remained relatively intact and tended to improve further over time, and PA was variably impaired over time, whereas metabolic suppression reactivity remained severely depressed. Regarding the interrelationships between these vasoreactive components, there was only a weak correlation between same-day, same-side CO 2 reactivity and metabolic suppression reactivity, and poor correlations between PA and CO 2 reactivity and between PA and metabolic reactivity. There were also often large hemispheric differences in vasoreactivity studies for metabolic suppression reactivity and PA, but such differences were typically minor for CO 2 reactivity. Intracranial hypertension was the only factor associated with impairment of all three vasoreactivity components, whereas a lower baseline CPP correlated with impaired CO 2 reactivity and PA. Selective impairment of CO 2 reactivity was seen in individuals with early hypotensive or hypoxic insults. Similarly, hemorrhagic lesions in or overlying the MCA territory were associated with selective impairment of ipsilateral metabolic suppression reactivity. Finally, the overall degree of vasoreactive impairment as defined by a cumulative vasoreactivity score correlated with the 6-month GOS score. These findings are discussed later in relation to previous studies of posttraumatic vasoreactivity and their potential clinical significance.
Methodological Issues
Transcranial Doppler ultrasonography is an established method of estimating moment-to-moment changes in CBF and, although indirect, it is based on substantial evidence that the cross-sectional area of the large-caliber vessels of the circle of Willis from which the TCD signal is derived does not change significantly during fluctuations in blood pressure and PaCO 2 .
2,26,31,58 Blood flow velocity changes in the insonated vessels are therefore proportional to changes in CBF. The strong correlation between the calculated CO 2 reactivity and the decrease in SjvO 2 during hyperventilation in our study further supports the concept that the change in TCD velocity is a true surrogate of the relative change in CBF. Given that this study involved the repeated performance of a lengthy three-part battery of tests for 6 or Xe-CT, 41 were deemed clinically unsuitable. Another advantage of TCD ultrasonography for this study was that discrete data were provided for each hemisphere that could then be related to focal abnormalities within the MCA territory.
Because multiple factors affect CBF in intubated patients, considerable effort was made to control these factors during vasoreactivity testing. Given that CO 2 reactivity was typically preserved in these patients, even relatively minor fluctuations in ETCO 2 could result in significant changes in MCA velocity that in turn would affect the final calculated PA index or metabolic suppression reactivity. This potential problem was minimized by correcting all flow velocities to an ETCO 2 of 34 mm Hg by using the patient's own hemispheric CO 2 reactivity values obtained during the same study session.
Similarly, because PA was often impaired, nine metabolic suppression studies were excluded when MAP changed by more than 10 mm Hg from the baseline value. With few exceptions, 6 previous vasoreactivity studies 18, 29, 54 and reports on pharmacological metabolic suppression 14, 33, 44 have not corrected for changes in CO 2 or blood pressure or excluded studies in which significant fluctuations in PaCO 2 or blood pressure occurred. For example, in the study by Cormio, et al., 14 of 67 severely head injured patients, induction of pentobarbital coma resulted in a mean decrease in ICP and MAP of 12 and 9 mm Hg, respectively. In our study, in which a relatively constant blood pressure was maintained with a phenylephrine infusion, induction of a propofol coma resulted in a mean decrease in ICP of 3 mm Hg.
The use of phenylephrine to prevent propofol-induced systemic hypotension and the resultant cerebral hypoperfusion that is independent of propofol's metabolic effects was thought to be justified and necessary. Adrenergic agents appear to blunt the hypotensive effect of agents like propofol by causing peripheral vasoconstriction without significant direct cerebrovascular effects, even after head injury. In a TCD ultrasonography study by Strebel, et al., 56 conducted in healthy individuals who were anesthetized with propofol, phenylephrine and norepinephrine had no effect on MCA flow velocity despite a 20% increase in MAP. In a cortical contusion injury study by Cherian, et al., 11 early postinjury infusion of phenylephrine increased CBF in the pericontusional area and contralateral hemisphere but only in proportion to the increase in MAP and CPP.
For several clinical reasons, including high ICP, low CBF, hemodynamic instability, and neurological improvement, complete batteries of tests for vasoreactivity could not be obtained over multiple days in all patients; however, the statistical analyses used accounted for variable numbers of studies nested within subjects. 35 As more patients are evaluated with this TCD-based battery of tests, a clearer picture of the time course and predictors of vasoreactive impairment should be delineated.
Reactivity of CO 2
In previous studies it has been demonstrated that CO 2
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Vasoreactivity changes after head injury reactivity is often impaired in the early stages after head injury and then generally recovers after 4 to 7 days. 13, 19 In two reports of severely head injured patients studied within 4 days of injury, globally impaired CO 2 reactivity was documented in 44% of subjects by using the 133 Xe method to measure CBF, and regionally impaired CO 2 reactivity was seen in more than 90% of patients tested with Xe-CT. 19, 36 In our study, global CO 2 reactivity was below normal in 55% of studies performed on postinjury Days 0 to 4; however, after Day 4, CO 2 reactivity was below normal in only 25% of patients. The most important clinical determinants of the state of CO 2 reactivity appear to be the baseline ICP and CPP, as well as early postinjury hypotension or hypoxia. A similar relationship between ICP and CO 2 reactivity was shown in the TCD study by Klingelhöfer and Sander. 27 Despite the association of high ICP with impaired CO 2 reactivity in the present study, hyperventilation resulted, on average, in a highly significant decrease in ICP.
Pressure Autoregulation
Using the 133 Xe method, disturbed PA has been seen in 31 to 50% of severely head injured patients during the first 10 days after trauma. 6, 19, 43 Impaired regional PA, either transient or persistent, was detected in 81% of 26 patients studied within 2 weeks of injury by Lam, et al., 29 who used laser Doppler flowmetry for their investigation. Our study also indicates that the temporal pattern of PA over the first 2 weeks postinjury varies across patients and does not consistently improve over time. As with CO 2 reactivity, the baseline ICP and CPP appear to be important determinants of altered autoregulation.
Interestingly, impaired PA was observed in almost two thirds of studies in patients with a baseline CPP of over 70 mm Hg. Additionally, on average, blood pressure elevation resulted in a significant albeit relatively small increase in ICP. These findings indicate that even though a higher CPP may favorably influence the state of PA, in the majority of instances, maintaining CPP above 70 mm Hg does not ensure normal PA. In patients with impaired PA, induced blood pressure elevation may result in hyperemia and worsening of intracranial hypertension. 6, 25 
Metabolic Suppression Reactivity
In previous studies it has been shown that CO 2 reactivity correlated strongly with the ICP response to barbiturates. 44 In the present study, however, we found only a weak correlation between same-day, same-hemisphere CO 2 reactivity and metabolic responsiveness to propofol. On average, propofol-induced electroencephalographically confirmed burst suppression resulted in only a 14% decrease in mean flow velocity, a value less than half the blood flow velocity decrease normally seen in healthy individuals and animals. 20, 22, 60 This blunted response to highdose propofol is likely in part related to the fact that global cerebral oxidative and glucose metabolism are already markedly depressed during the first 2 weeks after moderate or severe head injury. 5, 46, 50 Our study, however, also shows that other factors, including high ICP, ICH, and possibly vasospasm, may contribute to the degree of impaired metabolic responsiveness. This association of impaired metabolic suppression reactivity to ipsilateral ICH may be related to injury-induced release of vasoactive factors such as adenosine. 12, 28, 48 
Outcome and Vasoreactivity
Previous studies have linked poor neurological outcome after head injury with impairment of CO 2 reactivity, 27, 36, 46 PA, 16, 29 and responsiveness to metabolic suppressive therapy. 17, 44 Our investigation is unique in combining all three vasoreactive components to derive a cumulative vasoreactivity score. By so doing, a relatively strong correlation in 13 patients was found between this score and the 6-month GOS score. Admittedly, these findings are preliminary and warrant validation with a larger patient population that incorporates other known prognostic indicators in a multivariate statistical model.
Clinical Use of Vasoreactivity Data
This TCD-based battery of tests is being increasingly used to optimize and individualize ICP and CPP therapy in our daily management of head-injured patients. For example, individuals with poorly controlled intracranial hypertension, high SjvO 2 , and impaired PA are often effectively managed with judicious blood pressure reduction resulting in CPPs of 50 to 60 mm Hg and SjvO 2 values in the 60 to 70% range. Similarly, in patients with impaired metabolic suppression reactivity but relative preservation of CO 2 reactivity, high-dose propofol or pentobarbital can be used to minimize metabolic demands while aggressive hyperventilation is used to lower ICP. In such instances, PaCO 2 is often reduced to 25 mm Hg, provided that SjvO 2 remains above 60%. The overall effectiveness of more targeted treatments such as these in improving outcome after head injury remains to be proven.
Conclusions
This TCD-based study demonstrates markedly different degrees of impairment of CO 2 reactivity, PA, and meta- bolic suppression reactivity during the first 2 weeks after moderate or severe head injury. The relative degree of normalcy and the trend toward further improvement in CO 2 reactivity contrasts with the more variable pattern of PA and the persistent depression of metabolic suppression reactivity. Incorporating vasoreactivity data into the ICU management of head-injured patients will hopefully facilitate more targeted use of current and future ICP and CPP therapies.
